Anrukinzumab Antibody
Anrukinzumab (IMA-638) is a humanized anti-IL-13 monoclonal antibody. Its anti-inflammatory efficacy, validated in primate disease models, supports ongoing research for ulcerative colitis and asthma, including both in vivo and in vitro experimental applications.
Product Specifications
Product Name Alternative
IMA-638
Target
IL Receptor, Interleukin
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
5.15 mg/mL
Purity
97.00% (May vary between batches)
Molecular Weight
145.38 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
043869-ML490 100 µL
WFDC12, CT (WFDC12, C20orf122, WAP2, WAP four-disulfide core domain protein 12, Putative protease inhibitor WAP12, Whey acidic protein 2) (MaxLight 490) discontinued
Sign In for Pricing
View Details 
K2017606 1.0 µg DNA
RPS7P1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)
Sign In for Pricing
View Details